Cramer: Short Cover...
Health Care: Drugs
Meridian Bioscience Inc. (VIVO: NASDAQ)
$19.24 0.10 | 0.52%
05/24/12 - 04:00 PM ET
166.28K / 235.60K
Vol / Avg. Vol:19.19 / 19.14
Open / Prev. Close:18.78 - 19.25
Today's Range:14.81 - 27.37
52 Wk Range:2.12%
Performance YTD:TheStreet Rating:
Portfolios with VIVO
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorHighest-Yielding Drug Stocks
- Userhulkkims Portfolio 1
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE 20 Dividend Stoc...
- UserSUPRATRADE HOT STOCKS (BUY ...
- ContributorDividend Stocks for the Wee...
- Userrussbow98 Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
Latest VIVO Headlines from TheStreet
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 05.01.12 | 09:05 am
- 8 Stocks Rising on Huge Volume 04.20.12 | 01:04 pm
- Meridian Bioscience Inc. Stock Upgraded (VIVO) 03.29.12 | 05:03 am
- Meridian Bioscience Rises On Unusually High Volume (VIVO) 02.01.12 | 03:02 pm
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 01.31.12 | 09:01 am
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 11.16.11 | 10:11 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 10.03.11 | 09:10 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 09.21.11 | 02:09 pm
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 08.19.11 | 03:08 pm
- Meridian Bioscience Inc. Stock Downgraded (VIVO) 08.16.11 | 07:08 am
Press Releases for VIVO
- Meridian Bioscience Reports Record Second Quarter And First Six Months Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2012 Guidance - Business Wire 04.26.12 | 07:04 am
- Meridian Bioscience Awarded New Agreement With Premier Healthcare Alliance For Molecular Diagnostic Tests And Instruments For C. Difficile And Group B Streptococcus - Business Wire 04.12.12 | 05:04 pm
- Meridian Bioscience, Inc. To Release Fiscal 2012 Second Quarter Financial Results On April 26 - Business Wire 04.12.12 | 03:04 pm
- Bioline Celebrates 20 Years Of Service To Life Science - Business Wire 03.20.12 | 07:03 am
- Meridian Bioscience Receives FDA Clearance For New Legionella Test - Business Wire 02.27.12 | 01:02 pm
- Meridian Life Science® Successfully Manufactures Rhinovirus Challenge Stock - Business Wire 02.27.12 | 07:02 am
- Bioline Introduces New SensiFAST™ HRM Kit For Gene Mutations And SNP Analysis - Business Wire 02.16.12 | 07:02 am
- Meridian Bioscience Reports First Quarter 2012 Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2012 Guidance - Business Wire 01.25.12 | 07:01 am
- Bioline Introduces HyperPAGE II Broad Range Prestained Protein Marker - Business Wire 01.18.12 | 07:01 am
- Meridian Bioscience Receives FDA Clearance For ImmunoCard® C. Difficile GDH Test - Business Wire 12.27.11 | 11:12 am
Partner Headlines for VIVO
- Meridian Bioscience Receives FDA Clearance for New Legionella Test - Benzinga 02.27.12 | 01:02 pm
- UPDATE: Wedbush Downgrades Meridian Bioscience to Underperform - Benzinga 01.31.12 | 09:01 am
- Dividend Stocks That Combine Growth And Income - Seeking Alpha 01.20.12 | 08:01 am
- FDA OKs Meridian's GDH Test - Analyst Blog - Zacks 01.05.12 | 10:01 am
- 30 'Overdue' Dividend Increases -- Will History Repeat Itself? - Seeking Alpha 08.19.11 | 06:08 pm
- FDA OKs Meridian C. difficile Test - Analyst Blog - Zacks 05.13.11 | 09:05 am
- Meridian Bioscience: An Overvalued Dividend Contender - Seeking Alpha 04.12.11 | 06:04 am
- MF GLOBAL HLDGS (MF) - Profit Tracks - Zacks 02.10.11 | 01:02 am
- UPDATE 1-Meridian Bioscience Q1 misses Street view - Reuters 01.20.11 | 08:01 am
- Dividend Growth and the S&P 500 - Seeking Alpha 01.18.11 | 06:01 am
